Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00929708 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

329

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: AZD3199
DRUG: formoterol
DRUG: Placebo

Sponsor

AstraZeneca